The Effect of Contrast Agents on the Anticoagulant Properties of Oral Factor Xa Inhibitors
NCT04611386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65
Last updated 2020-11-02
Summary
The aim of this study is to evaluate the effect of iohexol as a contrast agent on the anticoagulant activity of oral factor Xa inhibitors.
Conditions
- Contrast Agents and Oral Factor Xa Inhibitor
Interventions
- DRUG
-
computerized tomography
Anti Factor Xa level
Sponsors & Collaborators
-
Bursa Postgraduate Hospital
lead OTHER
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2019-07-01
- Completion
- 2019-08-01
- FDA Drug
- Yes
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Drug-Induced Liver Injury (DILI) Network Retrospective
NCT00360646 ·Status: RECRUITING
-
Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence.
NCT03424330 ·Status: RECRUITING ·Phase: NA
-
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
NCT02460146 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration
NCT03324061 ·Status: COMPLETED ·Phase: PHASE1
-
Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver Injury
NCT04302506 ·Status: UNKNOWN
-
Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations
NCT04688008 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function
NCT01563562 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101
NCT01462786 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose in Participants With Liver Impairment and Healthy Participants Matched for Age-, Gender-, and Weight
NCT04322253 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess Injection Comfort of Two Formulations of ATX-101
NCT01320761 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers
NCT01074710 ·Status: COMPLETED ·Phase: PHASE1
-
Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.
NCT03091556 ·Status: UNKNOWN
-
PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function
NCT01429337 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions
NCT06249581 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Retrospective Study on Drug Induced Liver Injury in China
NCT02407964 ·Status: COMPLETED
-
Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)
NCT01004770 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants
NCT04155567 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers
NCT02393950 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function
NCT00759564 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function
NCT04476849 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics Study of AF-130 in Healthy Subjects
NCT02652936 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men
NCT02139826 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Selexipag in Healthy Male Participant
NCT04266756 ·Status: COMPLETED ·Phase: PHASE1
-
A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males
NCT04183517 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
NCT03529617 ·Status: RECRUITING